This year’s Journal looks different. It has more colour, more character and more columns. But the Journal’s ambition remains the same: to share the ideas shaping our thinking and informing the companies we invest in on behalf of our clients.
Executive Director Roy Leckie takes a look at what might lie ahead for equity markets, and remains bullish on the long-term outlook for the world’s leading companies.
Charlie Macquaker reflects on 34 years at Walter Scott, sharing insights from his early days to recent research trips in China and Sweden, and discusses the enduring principles that underpin the firm’s investment approach.
Discover how Novo Nordisk is navigating surging demand, pricing pressures and the rapid evolution of healthcare models in a fast-changing obesity market.
The information in this area of the website is intended for use by Institutional Investors and Consultants only. It is not intended for use by other investors including members of the general public.
By clicking “Yes” you hereby acknowledge, agree and represent to Walter Scott & Partners Limited that you are an Institutional Investor/Consultant and that you have read and understood the Terms and Conditions which apply.
The information contained on this page is not appropriate for, and should not be used or relied upon by, Retail Investors.
By clicking “No” you will be redirected to our Homepage.
Walter Scott & Partners Limited offers a variety of services intended solely for Institutional Clients from certain countries or regions. We do not offer these services outside of these intended countries or regions. Your country of legal residence will determine the services available to you. The information provided does not constitute an offer of or solicitation for purchase or sale of securities or provision of any investment services.